inTrODUcTiOn
The innate immune sensing apparatus, as originally proposed by Janeway (1) , serves two important functions: first, it is a means through which the host can recognize and respond rapidly to microbial pathogens; second, the innate immune machinery directs and regulates the ensuing adaptive immune responses so as to achieve maximum efficiency against the invading pathogens. Over the past 25 years, extensive experimental evidence has been amassed in support of both of these essential functions (2) . Particularly, recognition of conserved structures of pathogens by pattern recognition receptors such as toll-like receptors (TLRs) have been demonstrated to orchestrate both innate and adaptive immune responses (3, 4) . Upon binding to pathogen-associated molecular patterns, most TLRs signal through myeloid differentiation primary response 88 (MyD88), an essential cytoplasmic adaptor protein that links triggering of TLRs and IL-1/IL-18 receptors to downstream activation of IL-1 receptor-associated kinases (IRAKs) and the nuclear factor-kappa B (NF-κB) (5) . In turn, this initiates the production of various pro-inflammatory and immunoregulatory cytokines that control the subsequent development of antimicrobial B and T cell responses (6, 7) . However, the requirement of TLR/MyD88 pathway for antibody responses has been challenged by several studies demonstrating T-cell-dependent antibody synthesis in the absence of TLR/ MyD88 signaling (8) .
The importance of the TLR-MyD88 pathway in host defense against a variety of microbial pathogens has been extensively demonstrated (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . Despite this critical requirement for TLR/ MyD88 pathway for host defense against microbial infections, other studies demonstrated that it is dispensable for the generation of antibody responses, particularly in response to experimental infections by Salmonella enterica serovar Typhimurium (hereafter referred to as S. typhimurium) (17, 21, 22) and Borrelia burgdorferi (23) . These apparently conflicting findings even extend to the requirement of MyD88/TLR pathway for protective adaptive immunity to Salmonella infection. While one study reported that MyD88 deficiency had little effect on protection (22), we and others have shown that MyD88-deficient mice are profoundly susceptible to infection (17, 21) . Salmonella typhimurium bacteria are Gram-negative, food and water-borne pathogens that cause annually millions of cases of acute gastroenteritis, fever, and septicemia, representing a significant public-health problem worldwide (24, 25) . Notably, damage of host tissues during Salmonella infections has provided a link between Salmonella outbreaks and the development of autoimmune diseases (26) (27) (28) . However, the mechanisms behind these phenomena remain poorly understood, necessitating a better understanding of the host protective mechanisms in Salmonella infections.
To gain further insight into the role of TLR-MyD88 signaling in the immune response against Salmonella, we previously demonstrated that the inherent susceptibility of MyD88-deficient (MyD88 −/− ) mice to Salmonella infection is linked to a defective production of inflammatory cytokines and impaired recruitment of immune cells to the infection site (17) . Despite the observed defects, MyD88
−/− mice produced increased levels of anti-Salmonella IgG antibodies (17) , suggesting that Salmonella dysregulates the adaptive immune response. Here, we report a follow-up of our previous findings in which we characterized the activation state of innate (myeloid cells) and adaptive (T and B lymphocytes) immune responses from MyD88 −/− mice in response to an attenuated strain of S. typhimurium, designated BRD509E (29, 30) . Furthermore, we determined the underlying mechanism of the hypergammaglobulinemia response in BRD509E-infected MyD88 −/− mice as well as its implications for autoreactive B cell responses.
MaTerials anD MeThODs

Bacterial strains
For the current studies, we have used an attenuated aroA − /aroD − double auxotrophic mutant strain of S. typhimurium (BRD509E) cultured and prepared as previously described (30, 31) . Where indicated, we also utilized a strain of Acinetobacter baumanii (designated NM97), a clinical isolate from Tawam hospital, which was kindly provided by Dr. Tibor Pal (Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University). Heat-killed (HK) Salmonella was prepared by incubating log-phase bacterial suspension at 65°C for 1 h.
Mice
C57BL/6 wild-type mice (MyD88
) were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). MyD88-deficient mice (MyD88 −/− ) were generously provided by Dr. Shizuo Akira (Osaka University, Japan) (32) through Dr. Richard Flavell (Yale University School of Medicine, USA). Mice were bred in our animal facility and maintained in filter-topped isolator cages on Bactrim-supplemented water. Mice were taken off antibiotic for at least 7-10 days before use in any experiment. All animals were routinely used at 8-12 weeks of age when the bacteria were inoculated intraperitoneally (i.p.). All studies involving animals were conducted in accordance with and after approval of the animal research ethics committee of the College of Medicine and Health Sciences, United Arab Emirates University. In some experiments, sera from 8-week-old female autoimmune MRL/MpJ-Fas lpr (MRL-lpr) mice (Jackson Laboratory) were used for comparative determination of anti-double-stranded DNA (dsDNA) titers.
enumeration of Bacteria in Target Organs and Fecal Pellets
Procedures for determination of bacterial loads have been detailed elsewhere (17, 33) . Fecal CFUs were determined at the indicated time points by streaking fecal suspension on Salmonella-Shigella agar plates containing ampicillin and streptomycin. Similarly, bacterial CFUs were also determined in spleen and liver homogenates prepared in cold sterile saline.
spleen cell Preparation and enrichment
Erythrocyte-depleted spleen single cell suspensions were prepared as described previously (31) . Purification of CD4 + T cells and CD11b
+ myeloid subpopulations was done using magnetic bead separation on an autoMACS cell sorter (Miltenyi Biotec, Germany) according to manufacturer's instructions. The purity of CD4 + T cells was always between 90 and 95% and myeloid cells between 80 and 85%.
Phenotyping of splenic immune cell subsets
Processing of spleen cells for flow cytometric analysis was carried out as detailed previously (34) . Immunophenotyping of splenic myeloid cells was done using the following panel of conjugated mAbs: CD11b-eFluor780, Gr-1-FITC, Sca-1-PE, and CD80-APC (all from Biolegend or eBioscience, San Diego, CA, USA). For the analysis of splenic T population, we used a panel of mAbs consisting of CD3-FITC, CD4-PE-Cy7, CD8α-APC-Cy7, CD25-APC, and Sca-1-PE. Splenic B lymphocytes were analyzed using the following mAb panel: CD19-PE-Cy7, Sca-1-PE, CD80-APC, and CD86-FITC. In all staining groups, 7-AAD dye was included in order to exclude non-viable cells from the analysis. Data were collected on 30,000 cells using BD FACSCantoII cytometer and analyzed using BD FACSDiva software.
analysis of intracellular cytokine levels
The levels of intracellular cytokines were assessed as recently described (35) , with minor modifications. Briefly, spleen cell suspensions were seeded in 24-well plates and remained unstimulated or were stimulated with anti-CD3 (clone 2C11) mAb (5 μg/well) plus 100 µl of anti-CD28 (clone 37.N.51) at 20 μg/well for 24 h at 37°C in the presence of brefeldin A for the last 4 h of culture (GolgiPlug; BDcytofix/cytoperm plusTM solution kit, BD Biosciences). After overnight incubation, cells were harvested, stained with CD4-APC-Cy7 mAb (Biolegend), and intracellularly (BD Cytofix/Cytoperm Plus #555028) with anti-IFNγ-PE-Cy7 plus anti-IL4-APC or anti-IFNγ-PE-Cy7 plus anti-IL10-PE or isotype controls (all from Biolegend). Cells were read on a BD FACSCanto II and the data analyzed using BD FACSDiva software.
cytokine release
Purified splenic CD4
+ T cells were cultured in the presence or absence of plate-bound mAbs specific to murine CD3 and CD28 molecules, as described above. After overnight incubation, supernatants were harvested and analyzed for IFNγ, IL-4, and IL-10 cytokines by ELISA following the manufacturer's instructions (BD Biosciences).
gene expression analysis
Expression of target gene from purified and CD11b
+ myeloid and CD4
+ T cells was evaluated using qRT-PCR as previously described (34) using TaqMan reverse transcription reagents (Applied Biosystems, Foster City, CA, USA) and following the manufacturer's protocol. Briefly, TaqMan primers and probes (all from Applied Biosystems) were used to study the expression of various cytokines (including BAFF, IL-4, IL-6, IL-10, IL-12p35, IL-17F, IL-21, IFN-γ, and TGF-β), transcription factors (T-bet, GATA-3, RoRγ, Bcl-6, Foxp3), inducible nitric oxide synthase (iNOS), and the checkpoint protein PD-1. The levels of transcripts were normalized according to the ΔCq method to respective mRNA levels of the housekeeping gene hypoxanthine guanine phosphoribosyltransferase (HPRT). CFUs/mouse (for HK Salmonella), or 1 × 10 5 CFUs/mouse of A. baumanii. The presence of Salmonella-specific or Acinetobacterspecific antibodies of IgG1, IgG2c, IgG3, and IgM isotypes were determined by ELISA as previously described (17, 31) . Maxisorb microplates (Nunc, Roskilde, Denmark) were coated with 1 × 10 6 /ml HK BRD509E overnight. After blocking (1% BSA, 5% sucrose, 0.05% NaN3 in 1XPBS, pH 7.2-7.4), serum samples were titrated serially in the reagent diluent (1% BSA in 1XPBS, pH: 7.2-7.4) and incubated at room temperature (RT) for 2 h. After washing, the plates were incubated for 2 h with the respective biotin-conjugated anti-mouse Ig isotypes (goat anti-IgM, Jackson Immunoresearch, West Grove, PA, USA; goat anti-IgG1, goat anti-IgG2c, and rat anti-IgG3, all from Southern Biotech, Birmingham, AL, USA) followed by Streptavidin-HRP. The plates were developed using TMB substrate and read at 450 nm using a TECAN microplate reader (Maennedorf, Switzerland). For the quantitative determination of anti-Salmonella Ab concentrations, wells were coated with 0.1 µg/ml of goat anti-mouse Ig (H + L) Ab (Southern Biotech). After blocking with 2% BSA/PBS (pH 7.2) buffer, the standard curve was generated using specific mouse isotype Abs (IgG1 or IgG2c; starting concentration 50 ng/ml). For the rest of the plate, serum samples from individual animals were serially titrated in duplicate. The test plate was then incubated at RT for 2 h, washed extensively, and received appropriate secondary Abs (biotin-conjugated, isotype-specific Abs) and incubated for an additional 2 h at RT. After another series of washings, streptavidin-HRP was added and the plates developed using TMB, as described above.
Measurement of antibacterial antibodies
Determination of serum autoantibodies
The levels of autoantibodies directed against dsDNA, thyroglobulin, and mouse IgG rheumatoid factor (RF) were assessed by ELISA following a published method with modifications (36) . For the detection of dsDNA-specific Abs, Maxisorp plates were coated with 1 µg/ml of dsDNA (from calf thymus; Sigma) diluted in borate-buffered saline (BBS) overnight at 4°C. After three wash cycles, wells were blocked for 1 h at RT with BBS supplemented with 0.4% Tween 20 and 1.0% BSA. Serum samples (1/500 to 1/1,000 final dilutions) were then added and incubated for 2 h. After washing with BBS, the plates were incubated with biotin-conjugated goat-anti-mouse IgG, Fcγ-specific Ab (Jackson Immunoresearch) for 2 h at RT. Finally, the plates were incubated with Streptavidin-HRP and developed with TMB, as described above. For the detection of RF and anti-thyroglobulin antibodies, Maxisorp plates were coated overnight at 4°C with 1 µg/ml of either mouse IgG (Jackson Immunoresearch) for RF assay or thyroglobulin (from bovine thyroid; Sigma) diluted in 0.05 M carbonate buffer (pH = 9.6). Following three washes with PBS containing 0.05% Tween, the wells were blocked with PBS/ Tween/1% BSA for 2 h at RT. Serum samples, diluted to 1/1,000, were added in duplicate and incubated for 2 h at RT. The plates were then washed and developed using the same procedure described above.
Detection of antinuclear antibodies (ana) by immunofluorescence Using hep-2 cells
Serum ANA were detected by indirect immunofluorescence using a fluorescence-based HEp-2 ANA kit, according to the manufacturer's protocol (INOVA Diagnostics, San Diego, CA, USA). Diluted serum samples (1/80) and controls were incubated for 30 min at RT in a moist chamber. After gently rinsing with PBS, FITC-conjugated goat anti-mouse IgG (Pierce,) was added and incubated for 30 min, following which the mounting media was added and coverslip placed. The fluorescence was visualized at 40× magnification using an Olympus BX51 fluorescent microscope (Olympus Corporation, Japan).
histopathological Kidney analysis
Kidney biopsies were fixed in 4% paraformaldehyde, embedded in paraffin, and assayed for immune complex deposition. Tissue sections were stained with biotin-goat anti-mouse IgG (Fcγ-specific; 1/2,000 dilution) for 2 h followed by streptavidin-HRP (BD Biosciences) for 1 h. The peroxidase activity was determined using DAB chromogen (BD Biosciences). After washing, hematoxylin was added and sections were then rehydrated, mounted with DPX, and viewed under 20× and 40× light microscope.
statistical analysis
Statistical significance was analyzed using Student's t-test, using the statistical program of GraphPad Prism software (San Diego, CA, USA). Differences between experimental groups were considered significant when p values were <0.05.
resUlTs
Persistent infection by attenuated
We have previously demonstrated that MyD88 −/− mice are susceptible to infection by an attenuated strain of S. typhimurium (BRD509E) (17, 30) . While the lethal dose 50 (LD50) of the BRD509E strain in C57BL/6 mice, when given i.p., is ~5 × 10 6 CFUs per mouse, the equivalent LD50 in MyD88 −/− mice is ~400 CFUs/mouse, more than 10,000-fold lower than that of C57BL/6 mice. In this context, while i.p. inoculation of BRD509E (at doses as low as 4 × 10 2 CFUs/mouse) resulted in high mortality rates in MyD88 −/− mice, its oral administration led to the establishment of a chronic infection that lasted for more than 6 months (17). Here, we examined further the extent of the susceptibility to BRD509E in MyD88 −/− mice. We first followed the bacterial shedding in the feces over a 4-week period after the animals were infected i.p. with a low dose of BRD509E (200 CFUs/mouse). In wild-type MyD88 +/+ mice, only a low level of fecal shedding of S. typhimurium organisms (~10 CFUs/g feces) was observed 2 weeks postinfection ( Figure 1A) . By day 21, as the infection was phenotypically resolved, a minimal fecal shedding of S. typhimurium organisms was observed. In contrast, MyD88
−/− mice exhibited a persistent, progressively worsening infection accompanied by increasing levels of bacterial shedding over the 4-week observation period, reaching >10 5 CFUs/g feces ( Figure 1A ). This observation correlated with significantly elevated bacterial burden in the spleen and liver of infected MyD88 −/− mice, where the bacteria recovered was 158-and 240-fold greater, respectively, than in infected MyD88 +/+ mice ( Figures 1B,C) . Thus, MyD88 Figure 1D ). Sca-1 is an IFNγ-inducible activation marker on myeloid and lymphoid cells (37) and it has been shown to be upregulated in Salmonella infections (29) . Analysis of Sca-1 expression on splenic myeloid cells confirmed its upregulation on all three subpopulations ( Figures 1I-L,N) with the extent of activation being consistently higher in infected MyD88 −/− mice. This is most likely a reflection of the chronicity of Salmonella infection in these mice.
Given the persistent infection and increased infiltration of inflammatory myeloid cells into the spleens of MyD88 −/− mice at day 21 of infection, CD11b + cells were purified from different experimental groups and assessed for the expression of inflammatory mediators. We observed an elevated iNOS transcriptional activity in myeloid cells which reached >1,000-fold higher levels in both MyD88
+/+ and MyD88 −/− myeloid cells compared to NI −/− and MyD88 +/+ mice (*p < 0.05; **p < 0.01; ***p < 0.001).
animals (Figure 2A) , indicative of an ongoing pro-inflammatory milieu in both mouse strains. In agreement, equivalent levels of IL-12p35 and IL-6 were also evident in both NI and infected MyD88 +/+ and MyD88 −/− mice ( Figure 2B ). Of note, a significantly enhanced BAFF expression level was observed in infected MyD88 −/− mice compared to wild-type mice ( Figure 2C ). Given the important role of BAFF in driving autoreactive B cell responses (38, 39) , we also determined the levels of BAFF cytokine in mouse sera. Measurement of systemic BAFF levels revealed a 4.9-fold increase in BAFF in infected MyD88 −/− mice compared to infected MyD88 +/+ animals ( Figure 2D) . Interestingly, this analysis also showed significantly higher (threefold) BAFF serum levels in uninfected MyD88 −/− mice compared to their wild-type counterpart ( Figure 2D) . Additionally, Salmonella infection induced significant elevation (2.5-fold) in serum BAFF levels in MyD88 −/− mice compared to uninfected counterpart ( Figure 2D) . Collectively, these findings suggest a hyperinflammatory state of myeloid cells from MyD88 −/− mice in the context of a chronic infection with attenuated Salmonella. This is also combined with significantly elevated serum BAFF levels in MyD88 −/− mice.
enhanced T lymphocyte activation in the spleens of Salmonella-infected
Considering the interconnection between innate and adaptive immune responses (3, 40) , the abnormal activation displayed by splenic myeloid cells of MyD88 −/− animals suggested the possibility that Salmonella infection could also affect the activation of adaptive immune cells. The frequency of CD3 + T cells in NI wild-type mice was 33.1 ± 2.1 and was essentially unchanged (34.9 ± 2.2) at day 21 postinfection (Figures 3A-C) . Despite no changes in the absolute lymphocyte counts when comparing infected MyD88 +/+ with MyD88 −/− mice (Figure 1H) , the latter showed a slightly lower frequency of CD3 + cells (25.9 ± 1.5) in the T lymphocyte compartment (Figure 3B) . Since the frequency of CD4 + T cells was not abnormal in MyD88 −/− mice, the reduced CD3 + cells in the T lymphocyte compartment was probably due to low percentage of CD8 + T cells ( Figure 3D ).
Most important, phenotypic analysis of T cells upon Salmonella infection demonstrated an increased expression of Sca-1 on CD4
+ and CD8 + T cells from both mice strains (Figures 3E,F ; Figure S1 in Supplementary Material). However, the upregulation of Sca-1 expression was significantly higher on T cells from MyD88 −/− mice compared to wild-type mice. Furthermore, while we did not detect increased CD25 expression on T cells from infected wild-type mice when compared to NI animals, the absence of MyD88 resulted in a strong upregulation of this activation marker (Figures 3G,H ; Figure S1 in Supplementary Material). Therefore, the incapacity to control S. typhimurium infection in MyD88 −/− mice leads to a hyperactivation of innate and adaptive immune cells. +/+ and MyD88 −/− mice. Transcription of IFN-γ, the main cytokine that defines the Th1 signature, was significantly elevated (27-to 32-fold) upon Salmonella infection in both MyD88
+/+ and MyD88 −/− mice ( Figure 4A) . Noteworthy, CD4
+ T cells from MyD88 −/− spontaneously expressed increased levels of IL-4 and IL-21 when compared to wild-type mice, which are pivotal cytokines that define Th2 (43) (44) (45) and Tfh (follicular Th cells) (46, 47) profiles, respectively. After Salmonella infection, the amount of IL-4 and IL-21 was strongly upregulated in CD4 + T cells of MyD88 −/− , but not MyD88 +/+ , mice ( Figure 4A) . The expression level of IL-10, another Th2 cytokine (48) , was also elevated (~14-fold) in infected MyD88 −/− mice ( Figure 4A) . Interestingly, the enhanced Tfh-specific transcriptional signature was mirrored 
CD4
+ T cells from any mouse strain (data not shown) Overall, our data suggest that S. typhimurium infection exacerbates Th2 and Tfh transcriptional signatures, which are essential for the modulation of antibody production (49, 50) .
In order to validate our gene expression approach, we purified CD4 + T cells from NI and infected mice and analyze the T cells is typical of the cytokine pattern expressed by Tfh cells (51) . Recently, it was reported that naïve Th21 cells, which are implicated in autoimmune disease, do also express a combination of cytokines (IL-21 and IFNγ) typically associated with different Th cell lineages (52) .
Underlying the findings described above, we observed an upregulated expression of T-bet, the transcriptional factor responsible for Th1 differentiation, in CD4 + T cells from both mice strains ( Figure 4B) . Meanwhile, NI MyD88 −/− mice displayed a higher spontaneous gene expression of FoxP3, the transcription factor responsible for the differentiation of T regulatory (T reg) cells, compared to wild-type mice. However, following infection, the expression of FoxP3 was downregulated to levels comparable to those from wild-type mice. No changes were observed in the expression of GATA-3, RoRγ, or Bcl-6, which are responsible for the commitment of Th2, Th17, and Tfh cells, respectively ( Figure 4B) . Thus, despite the skilled T lymphocytes hyperactivation profile for Th2 and Tfh signatures, suggesting unique Th cell differentiation in infected MyD88 −/− mice, transcription factor expression profiling in total CD4 + T cells showed no substantial differences between MyD88 +/+ and MyD88 −/− mice, most likely due to the low sensitivity of the assay.
FigUre 5 | Hypergammaglobulinemia in Salmonella-infected MyD88
−/− mice. Mice were inoculated i.p. with BRD509 ( ~200 CFUs/mouse) and sera collected at 4 weeks and analyzed for the presence of Salmonella-specific IgM (a), IgG3 (B), IgG2c (c), and IgG1 (D) isotypes. Quantification of Salmonella-specific serum IgG2c (e) and IgG1 (F) antibodies in non-infected (NI) and 3-week infected (i) mice. Absolute antibody levels are expressed in micrograms per milliliter serum (n = 3-6 per group). (g-i) The kinetics of development of antibodies to Salmonella infection was evaluated during the first 3 weeks post i.p. infection with a dose of 4,000 CFUs/mouse. Salmonella-specific IgG3, IgG2c, and IgG1 were determined (n = 3-6 per group per time point). Asterisks denote statistically significant differences between MyD88 −/− and MyD88 +/+ mice (*p < 0.05; **p < 0.01; ***p < 0.001). Data are compiled from three independent experiments. (Figures 5A-D) . The absolute levels of Salmonella-specific IgG2c and IgG1 were also measured and the data confirmed the serum titers (Figures 5E,F) . The high IgG serum levels of anti-Salmonella antibodies in infected MyD88 −/− mice first became evident as early as 21 days post Salmonella inoculation (Figures 5G-I ) and was still significantly elevated up to 2 months later, the longest period of observation (data not shown). We also measured total IgG levels and observed that in NI animals, relatively low and comparable levels of serum IgG3 and IgG2c were detected in both MyD88
+/+ and MyD88 −/− mouse strains (Figures S4A,B in Supplementary Material), while IgG1 amounts in uninfected MyD88
−/− mice were significantly elevated compared to MyD88
FigUre 6 | Autoantibody reactivity of MyD88 −/− sera after systemic Salmonella infection. Sera were collected 4-6 weeks following i.p. infection with BRD509 (~200 CFUs/mouse) and tested for reactivity with thyroglobulin (a), rheumatoid factor [RF; (B)], and double-stranded DNA (dsDNA) (c) by specific ELISA. The cutoff for the detection of these autoantibodies was determined at 1/1,000 dilution. Data are compiled from three independent experiments. (D) Comparison of anti-dsDNA reactivity in sera of MRL-lpr (n = 3) and infected MyD88 −/− mice (n = 4). Serum reactivity with dsDNA was done at the indicated final dilutions (1/500 to 1/1,000). Non-infected sera are represented by the "Control" group. Data are representative of two independent experiments (*p < 0.05; **p < 0.01; ***p < 0.001). mice (2,303 ± 740 vs 626 ± 95 µg/ml, respectively; Figure S4C in Supplementary Material). In Salmonella-infected mice, serum IgG3 and IgG2c concentrations were significantly increased, by an average of threefold to fivefold over those in uninfected controls, in both mouse strains ( Figures S4A,B in Supplementary Material), while no significant changes in serum IgG1 concentrations were observed upon infection with Salmonella in both mouse strains. Noteworthy, the serum levels of all three IgG subclasses in infected MyD88
−/− mice were higher in relation to MyD88
. Hence, in addition to showing a humoral immune response that is constitutively skewed to Th2-induced IgG isotypes, MyD88
−/− mice challenged with attenuated Salmonella display hypergammaglobulinemia due to unresolved infection.
Presence of self-reactive B cells in MyD88
−/− Mice Following systemic Salmonella infection Considering the immune hyperactivation and potential etiological link between Salmonella infections and the development of autoimmune diseases (26-28), we analyzed the generation of autoantibodies in response to BRD509E. Mouse sera were collected 4-6 weeks following i.p. infection and tested for reactivity against dsDNA, thyroglobulin, and IgG. To rule out non-specific cross-reactivity, all autoantibody ELISAs were determined at a serum dilution of 1/1,000 or greater. Moreover, since all ELISAs were run using IgG-specific secondary antibodies, all observed reactivities reflect IgG isotype autoantibodies. No significant levels of autoreactive antibodies were detectable in wild-type (MyD88 +/+ ) mice before or after infection. Similarly, sera from NI MyD88 −/− mice had no reactivity to any of the autoantigens. On the other hand, Salmonella-infected MyD88 −/− mice displayed increased titers of autoantibodies directed against dsDNA (i.e., ANA), thyroglobulin, and IgG RF (Figures 6A-C) . In order to gain further insight about the physiological significance of the observed autoantibody levels, we compared the sera of Salmonella-infected MyD88 −/− mice with that of autoimmune MRL-lpr mice for reactivity to dsDNA. The MRL-lpr serum samples were collected from 8-week-old female mice and were positive at 1/100 dilution for −/− mice were incubated with HEp-2 cells, as described in Section "Materials and Methods." Positive staining showing homogenous (a), speckled (B), and cytoplasmic (c) patterns is shown. As a control, reactivity of sera from NI (e) or infected (F) MyD88 +/+ mice is also shown. The percentage of sera from the different experimental groups (n = 5-15 mice/group) that was positive for ANA is summarized in panel (g). The fluorescence was visualized at 40× magnification using an Olympus fluorescent microscope. Data are compiled from three independent experiments. ANA using the Euroimmun IIFT:HEp-20-10 cell test kit (data not shown). As shown in Figure 6D , a comparison of randomly selected individual serum samples showed that the levels of dsDNA-specific IgG autoantibodies in infected MyD88 −/− mice were comparable to, or higher than, those of MRL-lpr mice. Taken together, the data confirm that Salmonella infection of MyD88 −/− mice induces significant levels of autoantibodies of multiple specificities.
Sera were also tested for reactivity to fixed HEp-2 cells by immunofluorescence. Sera from infected MyD88 −/− mice exhibited different patterns of reactivity to dsDNA, ranging from homogenous to fine/coarse speckled (Figures 7A-C) . Importantly, sera from uninfected mice from both groups were negative for HEp-2 staining (Figures 7D,E) . While only 8% of the sera from infected MyD88 +/+ mice (1 out of 12) were positive for HEp-2 staining (Figure 7F ), approximately 53% of sera (8 out of 15) collected from infected MyD88 −/− mice showed strong reactivity to dsDNA in HEp-2 cells (Figure 7G ). These data suggest that different nuclear antigens are being recognized by the autoantibodies produced in infected MyD88 −/− mice. Given the state of hypergammaglobulinemia and the increased levels of serum IgG autoantibodies in infected MyD88
−/− mice, we next evaluated whether this fact was associated with more abundant immune complex deposition in kidney glomeruli. No evidence of staining was detected in the glomeruli of NI MyD88
−/− mice (Figures 8A,D) . In sharp contrast, much brighter staining, indicating more deposits of immune complexes, was detected in ~69% of Salmonella-infected MyD88 −/− mice (Figures 8B,C,G) while about 20% of infected MyD88 +/+ mice showed positive staining of glomeruli but those were generally of low level of intensity (Figures 8E,F) . Taken together, our data suggest that the absence of MyD88 predisposes animals to hypergammaglobulinemia, production of autoantibodies, and deposition of immune complexes in kidney glomeruli following infection with S. typhimurium.
requirements for infection-induced hypergammaglobulinemia and autoantibody Production
The next series of experiments were designed to study the requirements for the observed hypergammaglobulinemia and autoantibody synthesis in MyD88 −/− mice. We first asked whether infection with another Gram-negative bacterium, A. baumanii (strain NM970), could lead to similarly dysregulated antibody production in MyD88 −/− mice. Two months following inoculation, MyD88
−/− mice exhibited higher bacterial loads in spleen and liver when compared to MyD88 +/+ mice (Figures 9A,B) . Infected MyD88 −/− mice developed mainly IgG3 antibodies specific to Acinetobacter, but they were significantly lower (fourfold) than those observed in infected MyD88 +/+ mice ( Figure 9C) . No significant bacteria-specific IgG2c or IgG1 antibodies were detected (Figures 9D,E) . In addition, A. baumanii did not induce antibodies directed against dsDNA and thyroglobulin (Figures 9F,G) . Furthermore, there was no evidence of antibody dysregulation or autoantibody production in MyD88 −/− mice infected with the Gram-negative pathogen, Escherichia coli or with the Gram-positive bacterium Group B Streptococcus (Streptococcus agalactiae) (data not shown). Therefore, the development of 
autoreactive B cells in infected MyD88
−/− mice is dependent on the pathogen with which the animals are challenged.
We also tested the capacity of HK Salmonella (strain BRD509E) to induce hypergammaglobulinemia. Although triggering a larger production of IgG1 subclass in MyD88 −/− mice in comparison to wild-type mice, the antibody levels in sera were lower than those induced when MyD88 −/− mice were infected with live bacteria. HK Salmonella was unable to significantly trigger the production of IgG3 and IgG2 subclasses (Figures 10A-C) as well as ANA antibodies in both wild-type and MyD88 −/− mice ( Figure 10D) . These results indicate that the nature of Salmonella antigens is critical for the breakdown in B cell self-tolerance in MyD88 −/− mice.
DiscUssiOn
After penetration of epithelial barrier through M cells overlying the lymphoid follicles of Peyer's patches, S. typhimurium, which is an important model commonly used to study human immune responses to S. typhi (58) , typically infect macrophages, causing a self-limiting infection in the lamina propria. However, an impaired immune response can result in uncontrolled spread of bacteria into deeper organs such as spleen and liver, where the immune responses try to control the massive bacterial proliferation (22, 59, 60) . Here, we show that even low doses (~2 × 10 2 CFUs/mouse) of an attenuated strain of S. typhimurium (29, 31) can cause a disseminated disease in MyD88 −/− mice, as detected by shedding of bacteria in their stools, splenomegaly, and significantly elevated bacterial burden in spleen and liver compared to MyD88 +/+ mice. Our data are in agreement with Seibert et al. (22) who reported a defective control of bacterial spread in response to the attenuated Aro − strain SL7207 and Ko et al. (21) who demonstrated that MyD88-dependent innate immune responses are indispensable for protection against another attenuated strain of S. typhimurium. Taken together, the data described above suggest that despite the well-characterized phenotypic differences between MyD88-deficient mice and humans, both species are naturally highly susceptible to invasive Salmonella infections (16, 17) . Importantly, different attenuated bacteria have been designed to effectively work as live vaccines by inducing protection against invasive Salmonella diseases (61). Moreover, recombinant strains of Salmonella engineered to express immunomodulatory cytokines have been shown to boost innate and adaptive immune responses in normal as well as in immunodeficient hosts (13, 18, 29, 33, 62, 63) . The success of these preclinical studies promises to improve the public-health problems caused by Salmonella infections, such as those caused by multidrug-resistant strains (64) (65) (66) (67) (68) (69) and the high mortality of infected children (70, 71) . However, adverse side effects of live vaccines in MyD88-deficient patients have been reported (72) . Thereby, the translation of Salmonella live vaccines to the clinical routine will need to be carefully monitored to avoid severe adverse effects in infants with inborn errors of TLR signaling.
The establishment of persistent infections by bacterial species, such as S. typhimurium, is associated with considerable tissue damage, leading to hyperactivation of immune responses (28) (73) . Furthermore, MyD88 −/− mice develop dysregulated antibody responses characterized by increased serum levels of IgG, IgA, and IgM Salmonella-specific antibodies, production of anti-dsDNA autoantibodies, and deposition of immune complexes in kidneys in a TFH cell-dependent manner.
The apparent differences between the aforementioned studies could be due to different approaches such as the route of bacterial administration (17) and/or the bacterial strains used (74), thus requiring further investigation. Our present findings indicate that abnormalities of myeloid and T cells from MyD88 −/− mice contribute systemically to the development of an abnormal humoral immunity characterized by high serum levels of Salmonellaspecific IgM, IgG3, IgG2c, and IgG1 antibodies and enhanced levels of anti-dsDNA, anti-thyroglobulin, and IgG RF. Our data also suggest that the Salmonella-driven B cell activation (73, 75) is dependent upon the establishment of a chronic infection, since only live bacteria were able to induce hypergammaglobulinemia and autoantibody production in MyD88 −/− mice. Interestingly, the dysregulation of humoral immune responses in MyD88 +/+ animals, other bacterial species (A. baumanii, S. agalactiae, and E. coli) were unable to trigger the same phenomenon. Therefore, our findings provide an important link between environmental factor, genetic background, and the potential development of autoimmune diseases.
The hyperactivation of B cell responses in the context of a chronic infection in MyD88 −/− mice correlates with aberrant activation of myeloid cells and Tfh cells and the production of BAFF cytokine. Increased levels of BAFF breach B cell tolerance by enhancing survival of self-reactive B cells, thus allowing their abnormal entry into the mature follicular compartment where they can receive T cell help (76) . A suppressive role for B cell-intrinsic MyD88 expression has also been proposed (77) , which may well underlie the breakdown of B cell self-tolerance in our Salmonella infection model. Our current findings show that the autoantibody levels produced in chronically infected MyD88 −/− mice are comparable to, or higher than, those in autoimmune MRL-lpr mice. An inflammatory positive-feedback loop involving activated BAFF-producing myeloid cells and IFNγ-secreting T cells has been shown to play an important role in driving autoantibody production in autoimmune-prone mice (78) . Purified T cells of infected MyD88 −/− mice exhibited a heterogeneous cytokine expression pattern, including IL-21, IL-4, BAFF, IL-10, and IFN-γ and upregulated PD-1. Moreover, intracellular cytokine staining confirmed the increased presence of splenic T cells co-expressing IFN-γ plus IL-4 or IFN-γ plus IL-10 in Salmonella-infected MyD88 −/− mice. This heterogeneous cytokine expression profile is typical of Tfh cells (51) . Collectively, in the absence of MyD88, a persistent infection induces hypergammaglobulinemia and autoantibody development driven by the aberrant activation of myeloid cells and BAFF secretion. This, in turn, activates Tfh cells which consequently drive aberrant B cell responses.
In an attempt to translate our findings to humans, during approximately 10 years after the first report suggesting that the MyD88 signaling pathway is essential for the removal of autoreactive B cells, paradoxically neither autoreactive antibodies were identified in the serum of MyD88-deficient patients nor these subjects were reported to develop autoimmune diseases (72, 79) . However, very few MyD88-deficient patients have been characterized so far (72) . The clinical spectrum of MyD88-deficiency remains to be determined in different geographic regions of the world where MyD88-deficient subjects will enter in contact with different pathogens that could trigger the development of self-reactive B cells. In line with this hypothesis, during the time of manuscript preparation, a single Myd88-deficient patient and four with IRAK4 deficiency were reported to develop a particular pattern of self-reactive B cells, which are expanded during lupus flares, and speculated to be modulated by alterations in human microbiome (80) . This indicates that patients with MyD88 deficiency must be monitored for the development of autoreactive B cells and that improvement in the genetic diagnosis of this primary immunodeficiency worldwide could provide a priceless opportunity to uncover new MyD88-dependent mechanisms that orchestrate the adaptive immune response.
In conclusion, our findings expand the knowledge about the role of the TLR-MyD88 pathway in the host protection against Salmonella infections. Importantly, these data further characterize the dysregulation of adaptive immune system triggered by S. typhimurium in MyD88 −/− mice. Considering the link between Salmonella infections and the development of autoimmune diseases (26, 27, 81, 82) , future studies to further investigate the nature of immune dysregulation induced by Salmonella species in immunocompromised and immunocompetent hosts could reveal several novel important immunological mechanisms that can be explored as new therapeutic targets.
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